[Prospective study of the prognostic value of C reactive protein, alpha 1-antitrypsin and alpha 1-acid glycoprotein in acute pancreatitis]
- PMID: 1867921
[Prospective study of the prognostic value of C reactive protein, alpha 1-antitrypsin and alpha 1-acid glycoprotein in acute pancreatitis]
Abstract
Early recognition of severity of acute pancreatitis is very uncertain. For this reason it is necessary to have objective criteria to predict with accuracy the course of the disease. The aim of this study was to examine the value of the determination of the acute phase reactants: C reactive protein (CRP), alpha 1-antitrypsin (alpha-AT) and alpha 1-glycoprotein acid (alpha-GA) as prognostic indicators of acute pancreatitis on admission and on the third day. We have studied 40 patients with acute pancreatitis and serum concentrations of CRP, alpha-AT and alpha-GP were related to the Ranson Index. On admission the median levels of CRP: 74 mg/L, alpha-AT: 208 mg% and alpha-GA: 303 mg% were significantly higher (p less than 0.001) in patients with Ranson Index greater than or equal to 3 than in those with Ranson Index less than or equal to 2 (CRP: 166 mg/L, alpha-AT: 303 mg% and alpha-GA: 121 mg%). The values which differentiated patients with better and worse prognosis were: CRP 100 mg/L (sensitivity 100% and specificity 86%); alpha--AT 275 mg% (sensitivity 71% and specificity 85%); and alpha-GA 90 mg% (sensitivity 87.5% and specificity 57.9%). CRP, and to a lesser degree the alpha-AT and alpha-GA, were related to the duration of the ileus, and to the severe complications of the acute pancreatitis.
Similar articles
-
[Acute phase proteins in acute pancreatitis].Med Pregl. 1998 Sep-Oct;51(9-10):395-9. Med Pregl. 1998. PMID: 9863327 Croatian.
-
[C-reactive protein and lactate dehydrogenase as single prognostic factors of severity in acute pancreatitis].Lijec Vjesn. 2007 Jan-Feb;129(1-2):1-4. Lijec Vjesn. 2007. PMID: 17489509 Croatian.
-
Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.Br J Surg. 2002 Feb;89(2):163-71. doi: 10.1046/j.0007-1323.2001.01972.x. Br J Surg. 2002. PMID: 11856128 Clinical Trial.
-
Can markers for pancreatic necrosis be used as indicators for surgery?Am J Surg. 1990 Nov;160(5):459-61. doi: 10.1016/s0002-9610(05)81003-7. Am J Surg. 1990. PMID: 1700635 Review. No abstract available.
-
Prognostic factors in acute pancreatitis.Int J Pancreatol. 1993 Aug;14(1):1-8. doi: 10.1007/BF02795224. Int J Pancreatol. 1993. PMID: 8409572 Review. No abstract available.
Cited by
-
Extrapancreatic necrosis volume: A new tool in acute pancreatitis severity assessment?World J Clin Cases. 2021 Nov 6;9(31):9395-9405. doi: 10.12998/wjcc.v9.i31.9395. World J Clin Cases. 2021. PMID: 34877275 Free PMC article.
-
GlycA: Evaluation of a New Biomarker of Acute Pancreatitis.Biomolecules. 2023 Oct 16;13(10):1530. doi: 10.3390/biom13101530. Biomolecules. 2023. PMID: 37892212 Free PMC article.
-
Predictive factors for severe evolution in acute pancreatitis and a new score for predicting a severe outcome.Ann Gastroenterol. 2013;26(2):156-162. Ann Gastroenterol. 2013. PMID: 24714801 Free PMC article.
-
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD012645. doi: 10.1002/14651858.CD012645. Cochrane Database Syst Rev. 2017. PMID: 28431197 Free PMC article.
-
Measurement and analysis of unbound drug concentrations.Clin Pharmacokinet. 1996 Jun;30(6):445-62. doi: 10.2165/00003088-199630060-00003. Clin Pharmacokinet. 1996. PMID: 8792057 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous